Harleysville, PA, United States of America

Christina L Newton

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christina L Newton. Retrieved from https://idiyas.com/inventor/christina-l-newton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christina L Newton: Innovator in Thrombin Inhibition

Introduction

Christina L Newton is a notable inventor based in Harleysville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin inhibitors. Her work is essential for advancing medical treatments related to blood platelet aggregation.

Latest Patents

Christina holds 1 patent for her invention titled "Pyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhibitors." This compound is designed to inhibit human thrombin and includes structures and pharmaceutically acceptable salts that are useful for preventing the formation of blood platelet aggregates in mammals.

Career Highlights

Christina is currently employed at Merck & Co., Inc., a leading global healthcare company. Her role involves research and development in the pharmaceutical sector, where she applies her expertise to create innovative solutions for health challenges.

Collaborations

Throughout her career, Christina has collaborated with esteemed colleagues, including Richard C Isaacs and Adel M Naylor-Olsen. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Christina L Newton is a pioneering inventor whose work in thrombin inhibition is making a significant impact in the medical field. Her contributions are vital for improving treatments related to blood disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…